KaloBios Files for Bankruptcy - 24/7 Wall St.

KaloBios Files for Bankruptcy
24/7 Wall St.
KaloBios Pharmaceuticals Inc. (NASDAQ: KBIO) might be in too deep, and the same could be said for its recently appointed and then fired CEO, Martin Shkreli. The company filed for Chapter 11 bankruptcy on Tuesday morning, over a week after Shkreli was ...
Martin Shkreli's KaloBios has declared bankruptcyWZVN-TV
Martin Shkreli's other pharma company files for bankruptcyArs Technica
Martin Shkreli's KaloBios Pharmaceuticals files for bankruptcyUPI.com

all 383 news articles »